Medcura raises $7.4 Million to Expand FDA-Approved Line of Hemostatic and Wound Treatment Products

Funds will allow Medcura to expand its commercial footprint and support IDE submission for a new class of surgical hemostat RIVERDALE, Md., Aug. 12, 2021 -- (Healthcare Sales & Marketing Network) -- Medcura, Inc., a commercial-stage medical device comp... Devices, Surgery, Venture Capital Medcura, LifeGel, LifeFoam, hemostasis
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news